Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Terminated 3Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, Non-Hodgkin 70Lymphoma, Large B-Cell, Diffuse 67Lymphoma 66Lymphoma, Follicular 59Leukemia, Lymphocytic, Chronic, B-Cell 58Lymphoma, B-Cell, Marginal Zone 30Burkitt Lymphoma 30Waldenstrom Macroglobulinemia 24Lymphoma, Mantle-Cell 24Lymphoma, B-Cell 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia 19Recurrence 17Hodgkin Disease 12Neoplasms 10Lymphoma, Large-Cell, Immunoblastic 10Multiple Myeloma 8Leukemia, Prolymphocytic 8Leukemia, Myeloid, Acute 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Myelodysplastic Syndromes 7Mycosis Fungoides 6Lymphoma, T-Cell, Cutaneous 6Leukemia, Hairy Cell 6Sezary Syndrome 5Neoplasms, Plasma Cell 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, Extranodal NK-T-Cell 5Intraocular Lymphoma 5Dendritic Cell Sarcoma, Interdigitating 5

Interventions

Cyclophosphamide 4Rituximab 3cobomarsen 2Vincristine 2Prednisone 2Etoposide 2Doxorubicin 2thymoglobulin 1ponatinib 1ibritumomab tiuxetan 1fludarabine phosphate 1fludarabine 1Vorinostat 1Tacrolimus 1Mycophenolic Acid 1Melphalan 1Imatinib Mesylate 1Ifosfamide 1Cytarabine 1Carmustine 1Carboplatin 1Busulfan 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Immune System Diseases × Rituximab × Clear all
NCT02592876 2019-05-17

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Seagen Inc.

Phase 2 Terminated
81 enrolled 15 charts
Lymphoid

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT02855359 2019-03-11

Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Seagen Inc.

Phase 2 Terminated
24 enrolled 10 charts
Lymphoid

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT02366663 2018-03-12

SPINOZA

City of Hope Medical Center

Phase 3 Terminated
3 enrolled 8 charts
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡